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The widespread use and abuse of antibiotic therapy has evolutionary and ecological con-
sequences, some of which are only just beginning to be examined. One well known
consequence is the ﬁxation of mutations and lateral gene transfer (LGT) events that confer
antibiotic resistance. Sequential selection events, driven by different classes of antibiotics,
have resulted in the assembly of diverse resistance determinants and mobile DNAs into
novel genetic elements of ever-growing complexity and ﬂexibility. These novel plasmids,
integrons, and genomic islands have now become ﬁxed at high frequency in diverse cell
lineages by human antibiotic use. Consequently they can be regarded as xenogenetic
pollutants, analogous to xenobiotic compounds, but with the critical distinction that they
replicate rather than degrade when released to pollute natural environments. Antibiotics
themselves must also be regarded as pollutants, since human production overwhelms
natural synthesis, and a major proportion of ingested antibiotic is excreted unchanged into
waste streams. Such antibiotic pollutants have non-target effects, raising the general rates
of mutation, recombination, and LGT in all the microbiome, and simultaneously provid-
ing the selective force to ﬁx such changes. This has the consequence of recruiting more
genes into the resistome and mobilome, and of increasing the overlap between these
two components of microbial genomes. Thus the human use and environmental release
of antibiotics is having second order effects on the microbial world, because these small
molecules act as drivers of bacterial evolution. Continued pollution with both xenogenetic
elements and the selective agents that ﬁx such elements in populations has potentially
adverse consequences for human welfare.
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INTRODUCTION
The discovery of antibiotics and their use in the treatment of bac-
terial infections was one of the major scientiﬁc achievements of
the 20th century. However, over the last 60 years, there has been
a spectacular and rapid evolution of antibiotic resistant strains
of bacteria. This has culminated in the appearance of pathogens
with resistance to a wide range of antibiotics, and a rise of sim-
ilarly resistant opportunistic organisms (Davies, 2007; Davies
and Davies, 2010). Antibiotic resistance is a critical problem for
humans and their domestic animals, and is recognized as such by
workers in government, clinical practice, research, and industry
(Bush et al., 2011).
The focus of research and thinking about this problem has
mainly been from an anthropogenic viewpoint. However, at its
heart, antibiotic resistance is an environmental and evolution-
ary problem. Humans are now the greatest evolutionary force
on the planet (Palumbi, 2001), and it would help us understand
and manage the resistance problem to investigate resistance from
a broader perspective, most notably in terms of the interplay
between ecology, evolutionary dynamics, and natural selection.
A number of authors are now thinking about the ecology and nat-
ural history of antibiotics and resistance genes. This approach
will inform clinical and veterinary practices and will improve
our understanding of evolutionary processes (Aminov and
Mackie, 2007; Baquero et al., 2009; Fajardo et al., 2009; Stokes
and Gillings, 2011).
There is evidence that the antibiotic revolution may have sec-
ond order effects, and is inﬂuencing the evolution of the entire
microbial biosphere (Martinez, 2008; Baquero, 2009; Couce and
Blázquez, 2009; Gillings and Stokes, 2012). This paper attempts to
place antibiotics, resistance genes, their vectors, and their hosts
into an evolutionary perspective. By understanding the evolu-
tionary history of these genes and molecules, we place ourselves
in a better position to predict their future (Martinez et al., 2007;
Courvalin, 2008; Conway Morris, 2010).
THE NATURAL HISTORY OF ANTIBIOTICS
The term “antibiotic” reﬂects our anthropocentric viewpoint.
Antibiotics are not a discrete class of molecules, but rather, encom-
pass a broad range of structural and molecular families, united by
their ability to inhibit microbial growth at high concentrations.
The original use of the word “antibiotic” was a generic term that
simply reﬂected the outcome of a laboratory test (Waksman, 1973;
Davies and Davies, 2010). In modern terms, an antibiotic has
broadly come to mean any synthetic or naturally occurring low
molecular weight molecule that inhibits bacterial growth.
It is clear that there are millions of low molecular weight
compounds in natural environments, and that in high enough
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concentrations some of these could exhibit an antibiotic effect.
However, it is unlikely that such compounds ever reach inhibitory
concentrations in nature, and there is a growing realization that
their primary role is not necessarily in cross-species warfare, but
may largely lie in cell–cell communication (Linares et al., 2006).
This change in viewpoint began with the discovery of bacterial
quorum sensing, a system that allows communication between
cells of the same or different species via signaling molecules called
auto-inducers. Quorum sensing is found in diverse organisms,
and the scale and extent of signaling systems in general has led
to the revelation that the microbial world is in a state of constant
and complex communication (Lyon and Muir, 2003; Henke and
Bassler, 2004; Stevens et al., 2012). Consequently, many of the
small molecules produced by bacteria may be involved in addi-
tional forms of communication between cells. The compounds
we know as “antibiotics” are a minor subset of this world of small
molecules.
The growth-inhibiting concentrations of antibiotics used in
clinical practice are unlikely to ever be reached via natural syn-
thesis, and consequently, antibiotics probably have signiﬁcant
effects at sub-inhibitory concentrations, without affecting bac-
terial growth rates. It has now been shown that sub-inhibitory
concentrations of various antibiotic classes have effects on gene
transcription. Up regulation and down regulation of diverse genes
has been demonstrated, with some estimates suggesting that as
many as 5% of gene promoters might be affected (Goh et al., 2002;
Linares et al., 2006). Some antibiotic classes modulate expres-
sion of particular genes (Tsui et al., 2004). The types of functions
affected are diverse, including genes for protein synthesis, carbo-
hydrate metabolism, transport/binding proteins and genes of as
yet unknown function (Goh et al., 2002; Lin et al., 2005).
The cascade of gene expression induced by sub-inhibitory
concentrations of antibiotics leads to phenotypes of adaptive sig-
niﬁcance. These include ﬂagella biosynthesis and the ability to
colonize biotic and abiotic surfaces (Seshasayee et al., 2006). As
might be expected, some of these phenotypes have direct rele-
vance for species–species interactions and responses to host cells,
such as virulence, bioﬁlm formation, and motility (Goh et al.,
2002; Hoffman et al., 2005; Linares et al., 2006; Marr et al., 2007;
Shank and Kolter, 2009). Collectively, these observations strongly
suggest that the antibiotics used in medical treatment are a small
subset of the diverse secondary metabolites used in the microbial
world for signaling and other cell–cell interactions. Their clinical
use is based on a serendipitous ability to inhibit growth at unnat-
urally high concentrations. There is a growing realization that the
discovery, clinical use, and evolution of antibioticsmust be consid-
ered against the background of their roles in natural environments
(Davies et al., 2006; Yim et al., 2007; Fajardo and Martínez, 2008;
Ryan and Dow, 2008).
A GENERIC MODEL OF SMALL MOLECULE SIGNALING
Thinking about antibiotics as a subset of signaling molecules
allows us to construct simple conceptual models that might
establish some general principles about antibiotics and antibi-
otic resistance (Figure 1). A signaling molecule must be made
by a metabolic pathway, whose enzymes are encoded by genes (A,
B, and C in Figure 1). Any intermediate small molecule in this
pathway can be exported as a signaling molecule, most probably
using an efﬂux pump. Small molecules then diffuse into envi-
ronmental space, where they can bind to receptors on the cell
surface of the producing species (intra-species signaling), or to
cell surface receptors of different species (inter-species signaling).
Alternatively, small molecules can be imported into cells via a
membrane transport protein, and then bind to a target within the
cell (Figure 1). Binding of signaling molecules can inﬂuence tran-
scription or biochemical pathways, and thus affect the phenotypic
attributes of the receptor cell.
This conceptual model (Figure 1) allows us to consider antibi-
otics and resistance from a different and broader perspective.
Antibiotics can be thought of as a subset of small biosynthetic
molecules, albeit those which happen to have the property of
inhibiting bacterial growth at high concentrations. Given the fact
that bacteria have been evolving and interacting for some 3.8 bil-
lion years, it should not be surprising that the genes encoding
biosynthetic and catabolic pathways for small molecules have
an ancient evolutionary history. Pathways for synthesis of ery-
thromycin and streptomycin date to more than 600 million years
ago (Baltz, 2005), and it has been estimated that the serine β-
lactamases date back 2billion years (Hall andBarlow,2004). Under
this view “antibiotics” predate humans by some billions of years.
Note that the use of an intermediate in the biosynthetic path-
way as a signaling molecule (Figure 1, triangle) means that
FIGURE 1 | Conceptual schematic illustrating the production,
export, and target sites of a small molecule biosynthetic cluster.
The metabolic pathway for synthesis of a small molecule is encoded
by genes A, B, and C. One of the intermediates (triangle) is exported
from the cell via an efﬂux pump, where it can then bind to cell surface
receptors, or enter a second cell via a membrane transport protein.
Inside the second cell there may be binding sites on additional
target molecules. Most of the molecules we know as antibiotics
may be a subset of this more general class of signal-receptor
systems.
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the producing cell already encodes an enzyme capable of mod-
ifying the signal molecule. Under other circumstances, such
a gene might confer resistance to high concentrations of the
agent. Many biosynthetic gene clusters that make “antibiotics” are
also known contain genes that confer “resistance” to those same
antibiotics (Pootoolal et al., 2002; Huang et al., 2005). Given that
gene clusters for secreted molecules are frequently subject to lat-
eral gene transfer (LGT; Fischbach et al., 2008; Nogueira et al.,
2009), it should not be surprising that there is clear evidence
for lateral transfer of antibiotic resistance genes from environ-
mental bacteria into pathogens (Gillings et al., 2008a,b; Forsberg
et al., 2012).
Small molecules can exit the producing cell via a wide diver-
sity of membrane bound efﬂux pumps (Figure 1; Paulsen et al.,
1996; Desvaux et al., 2004; Poole, 2005; Bay and Turner, 2009),
each of which, in turn, may be able to export diverse molec-
ular species (Zgurskaya and Nikaido, 2000; Kuete et al., 2011).
Such pumps have evolved as mechanisms to export natural sub-
stances produced internally, or those that are produced by other
cells (Martinez et al., 2009b). Efﬂux pumps may also be essen-
tial for colonizing and persisting in eukaryotic hosts (Piddock,
2006). It is thus clear that antibiotic resistance mediated by
efﬂux pumps is a side-effect of a more general molecular export
system.
Genes for efﬂux pumps are commonly found in bacteria
that produce antibiotics (Petkovic´ et al., 2006), and these genes
are often found embedded within biosynthetic gene clusters for
antibiotics, thus conferring efﬂux ability (and “resistance”) on
the producing organism (Méndez and Salas, 2001). Again, the
“resistance” gene is preexistent, and located within a gene cluster
characterized by LGT (Nogueira et al., 2009).
Once exported from the cell, a signaling molecule is free to bind
with receptors on the surface of neighboring cells (Figure 1). Point
mutations in the genes for these receptors might alter the bind-
ing site and thus generate a “resistance” phenotype. Alternatively,
the signaling molecule may be taken up by a membrane trans-
port protein and imported into a new cell. A surprising diversity
of bacteria make use of such transport proteins to import small
molecules such as antibiotics, which they can then use as a sole
carbon source (Dantas et al., 2008). Lateral transfer of the genes
for such catabolic processes would confer resistance on the recip-
ient cell. Resistance could also be generated by mutation to the
gene encoding the membrane transport protein, preventing entry
of the signaling molecule. Once inside a recipient cell, a signaling
molecule may bind to a target site, and thus exert an effect. Muta-
tion of the gene encoding the target site may abolish binding and
prevent the effect. In the case of an antibiotic, such a change would
be called a resistance mutation.
Although the model I have presented above is simplistic, nev-
ertheless it has good explanatory power for understanding the
ecology and evolution of both antibiotics and their correspond-
ing resistance genes. Antibiotics are seen as a subset of a diverse
group of small molecules whose primary function is in cell–cell
interactions. Genes for synthesizing, transporting, and cataboliz-
ing these smallmolecules can be co-opted as resistance genes when
cells are exposed to unnaturally high concentrations of these com-
pounds. The high frequency of lateral exchange of biosynthetic
gene clusters for small molecules (together with their associated
efﬂux pumps and catabolic functions) explains the penetration of
efﬂux pumps and degradative enzymes into species unrelated to
the original “antibiotic” producer.
ANTIBIOTICS, RESISTANCE GENES, AND THE GLOBAL
MICROBIOME
In thinking about the ecology and evolution of antibiotics and
resistance genes, we can summarize the sub-components upon
which selection can act in a series of Venn diagrams (Figure 2).
The largest category is the Global Microbiome, encompassing all
the prokaryotic cells in the biosphere. Thismay contain 4–6× 1030
cells and hold a signiﬁcant proportion of the carbon, nitrogen, and
phosphorus found in living things (Whitman et al., 1998). The
phenotypes exhibited by the global microbiome are encoded by
the microbial Pangenome, that is, the set of genes present in all
the genomes of all the prokaryotes in the biosphere (Medini et al.,
2005; Tettelin et al., 2008; Lapierre and Gogarten, 2009). Estimates
of the composition of the pangenome have been made, based
on the rapid accumulation of bacterial genome and metagenome
sequences. Some 250 gene families are common to all bacterial
genomes (the extended core genome) and about 8,000 gene fam-
ilies are niche-speciﬁc genes essential for survival in particular
environments (the character genome). The bulk of pangenomic
diversity comprises more than 139,000 gene families that occur
as accessory genes, these being found dispersed amongst single
strains, serovars or species (Lapierre and Gogarten, 2009). The
combined coding capacity of the pangenome is expressed as the
Panproteome, this being the sum of all the proteins encoded and
produced by the microbial realm.
A proportion of the pangenome is highly mobile, and able
to move comparatively freely between prokaryote species in the
process known as LGT. Elements that specialize in moving DNA
within and between genomes include plasmids, transposons, inte-
grons, insertion sequences, and integrative conjugative elements.
These elements and the genes they carry are collectively known as
the Mobilome (Figure 2; Siefert, 2009; Leplae et al., 2010). In prin-
ciple, and over evolutionary timescales, any part of the pangenome
can be mobilized by LGT. The mobilome helps to generate enor-
mous diversity within prokaryote genomes by recombination
between various mobile elements to create a series of complex
mosaic structures (Garriss et al., 2009; Toleman and Walsh, 2011;
Toussaint and Chandler, 2012).
TheResistome is deﬁned as the collection of all genes that could
contribute to a phenotype of antibiotic resistance (D’Costa et al.,
2006; Wright, 2007, 2010; Forsberg et al., 2012). This is a purely
functional deﬁnition made from a human and medical point of
view, for as we have seen, the resistome encompasses diverse
genes whose original functions were not simply for avoiding the
effects of antibiotics. Nevertheless, it is a useful concept, because
it underscores the point that resistance genes originate from envi-
ronmental bacteria. A database of antibiotic resistance genes has
been developed (Liu and Pop, 2009), but the 20,000 genes already
listed are only a small proportion of the resistome, since inves-
tigation of soil metagenomes has revealed diverse and divergent
resistance genes capable of dealing with multiple classes of antibi-
otic (Riesenfeld et al., 2004; Allen et al., 2008). Genes encoding
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FIGURE 2 | Conceptual representation of the biological molecules of
relevance to antibiotic resistance.The small cross-hatched boxes
represent the antibiotics and resistance genes of relevance to clinical
practice. Respectively, these are a small subset of the world of small
bioactive molecules (the parvome), and the world of potential resistance
determinants (the resistome). The resistome comprises the genes that
potentially encode resistance to antibiotics. The mobilome comprises the
mobile proportion of bacterial genomes. The mobilome and resistome
overlap, since many resistance genes are located on mobile elements.
Both the resistome and mobilome are a subset of the total coding capacity
of prokaryotic cells, the pangenome, which is expressed as the
panproteome. Note that only a small proportion of the parvome is utilized
by humans for antibiotic purposes, and that the scale of commercial
antibiotic production probably overwhelms the natural production of these
molecules by the entire global microbiota.
antibiotic resistance are ancient components of the pangenome,
since they have been recovered from 30,000 year old permafrost
(D’Costa et al., 2011), and from a cave microbiome that has been
isolated for 4 million years (Bhullar et al., 2012). Note that the
resistome overlaps with the mobilome (Figure 2), because many
antibiotic resistance genes are found on mobile elements, allow-
ing the resistome to be widely disseminated by LGT (Norman
et al., 2009; Fondi and Fani, 2010; Skippington and Ragan, 2011).
Also note that the resistance genes and mobile elements that are
of concern for clinical antibiotic resistance (cross-hatched box,
left hand side Figure 2) are just a fraction of the resistome and
mobilome.
The Parvome is the world of small bioactive molecules pro-
duced by cells (also sometimes called secondary metabolites). The
parvome includes important classes of molecules such as polyke-
tides, aminoglycosides, terpenoids, alkaloids, and non-ribosomal
peptides,many of which have antimicrobial activity (Davies, 2011;
Davies and Ryan, 2011). The parvome overlaps with the proteome,
because some of these small bioactivemolecules are peptides. Note
however, that only a small proportion of the parvome is utilized
by humans for its antimicrobial properties (cross-hatched box,
right hand side Figure 2). Commercial production of antibiotics
overwhelms their natural synthesis, such that humans are now the
major source of antibiotics in the general environment (Figure 2;
Sarmah et al., 2006; Davies and Davies, 2010).
EVOLUTIONARY CONSEQUENCES OF THE ANTIBIOTIC AGE
Having examined the relationships between the key components
of relevance to antibiotic production and resistance (Figure 2), we
can now examine how each might be affected by human activity.
There are several potential dimensions to these effects, including
changes to the abundance and diversity of each component, and
whether the effects are transient or permanent.
THE PARVOME
Antibiotics are released into the environment via human waste
streams because a signiﬁcant proportion of prophylactic antibi-
otics are excreted essentially unchanged (Sarmah et al., 2006;
Le-Minh et al., 2010). Although it is difﬁcult to obtain precise
estimates for commercial production of antibiotics, it probably
amounts to millions of metric tons per year (Segura et al., 2009).
Because of the volume of antibiotics generated by human activity,
the majority of the environmental load of antibiotics now orig-
inates from this commercial production (Figure 2; Davies and
Davies, 2010). Certainly the local concentrations of this subset
of the parvome have markedly increased due to human activity.
Further, the diversity of small bioactive molecules has increased,
because many antibiotics are synthetic modiﬁcations of natural
structures. There is now a zone of inﬂuence around all human
activities where the abundance and diversity of the parvome is
increased. Such zones increase selective pressures on the local
microbiome, not just the intended targets of antibiotic therapy
(Martinez et al., 2009a; Taylor et al., 2011), and may also interfere
with cell–cell communication.
THE RESISTOME
Increasing the concentration of antibiotics in the environment
has effects on both the diversity and the abundance of genes
belonging to the resistome. Selection for cells that carry resis-
tance determinants increases their relative abundance, and thus
increases the abundance of genes that confer resistance. Further,
the ability of many elements of the resistome to undergo LGT,
means that identical resistance genes can now be found in diverse
bacterial species, from clinical contexts, from domestic animals,
wild animals, and in locations apparently distant from the inﬂu-
ence of developed societies, such as the Arctic, Antarctica, and
the Amazonian jungle (Pallecchi et al., 2008; Sjolund et al., 2008;
Bartoloni et al., 2009; Stokes and Gillings, 2011). That humans
are responsible for this phenomenon is demonstrated by the pos-
itive correlation between the abundance of resistome elements of
clinical signiﬁcance and proximity to human activity (Skurnik
et al., 2006; Hardwick et al., 2008; Thaller et al., 2010; Nardelli
et al., 2012).
Selection pressure is particularly acute in humanwaste streams,
where resistance genes are shed, mixed with high concentrations
of antibiotics and other selective agents (Baquero et al., 2008;
Schlüter et al., 2008; Moura et al., 2010). Exposure of environmen-
tal microorganisms to this mixture encourages ﬁxation of LGT
events, spreading elements of the resistome into diverse strains
and species, thus further increasing their abundance, and their
penetration into new hosts and niches.
Exposure to sub-inhibitory concentrations of antibiotics
induces expression of error-prone DNA polymerases, increasing
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the basal mutation rate (Kohanski et al., 2010; Thi et al., 2011).
This has the effect of generating additional genomic diversity, and
of co-opting additional genes into the resistome via mutational
changes to housekeeping or accessory genes whose original func-
tion was not antibiotic resistance (Dantas and Sommer, 2012).
As a second order effect, constant low level antibiotic exposure
selects for lineages with inherently higher rates of mutation, gen-
erating additional diversity across the entire pangenome via drift
and selection (Earl and Deem, 2004; Pigliucci, 2008; Couce and
Blázquez, 2009; Gillings and Stokes, 2012).
Human activity has increased the abundance of resistome ele-
ments by selection, as shown by their increase in frequency in soils
collected over the last 70 years (Knapp et al., 2009), and by their lat-
eral transfer to diverse species. We have also increased the diversity
and membership of the resistome by ﬁxation of de novo mutations
and by the co-option of genes as resistance determinants. Thus
the size of the resistome, as a proportion of the pangenome, is
probably becoming larger (Figure 2).
THE MOBILOME
The clinical use and environmental dissemination of antibiotics
has had signiﬁcant effects on the abundance and diversity of ele-
ments within the mobilome. Selection for antibiotic resistance
has ﬁxed lineages carrying diverse resistance determinants on a
similarly diverse array of mobile elements. Such complex mobile
elements now occur at high frequency in human-dominated sys-
tems, and in more natural ecosystems, where they can move by
LGT into environmental organisms (Chee-Sanford et al., 2001;
Nagachinta and Chen, 2008; Schlüter et al., 2008; Gillings et al.,
2009a; Pellegrini et al., 2009).
The very use of antibiotics may itself increase the frequency
of LGT, and thus the penetration of elements of the mobilome
into new bacterial hosts (Beaber et al., 2004; Úbeda et al., 2005;
Prudhomme et al., 2006). This effect is driven by the bacterial SOS
response, which temporarily increases both the basal rate of LGT
and of recombination (Tenaillon et al., 2004; Schlacher and Good-
man, 2007). There is also evidence that human activities actually
select for bacteria with a permanently increased propensity for
LGT (Gillings and Stokes, 2012). Consequently, antibiotic pollu-
tion creates hotspots for the assembly of complex, mosaic mobile
elements from diverse sources, and provides a selective force for
their subsequent ﬁxation in diverse lineages (Szczepanowski et al.,
2005; Schlüter et al., 2008; Gillings et al., 2009b).
The accumulation of diverse mobile elements within single
plasmids or at single loci provides opportunities for complex
rearrangements and recombination events that in turn, gener-
ate more diversity (Garriss et al., 2009). The emergent properties
that arise as mobile elements gain more components means that
they can effectively increase their own complexity (Krizova et al.,
2011; Toleman and Walsh, 2011). This phenomenon is evident in
the increasing complexity and phenotypic plasticity of genomic
islands and integrative conjugative elements in emerging nosoco-
mial pathogens such as Pseudomonas aeruginosa andAcinetobacter
baumannii (Fournier et al., 2006; Klockgether et al., 2011).
The selective forces acting upon complex mobile elements are
not restricted to antibiotic pressure. Mobile DNAs often carry
genes conferring resistance to other selective agents, such as
heavy metals, arsenic, and disinfectants. Exposure to any one
of these agents selects for lineages containing mobile elements
with appropriate resistance genes, and simultaneously ﬁxes all
the other genes in physical linkage on that element, including
antibiotic resistance determinants. Such co-selection of antibiotic
resistance has long been thought to arise as a consequence of pol-
lution with heavy metals (Baker-Austin et al., 2006; Salyers and
Shoemaker, 2006; Stepanauskas et al., 2006; Wright et al., 2008;
Rosewarne et al., 2010; Drudge et al., 2012). Disinfectant use also
results in co-selection of antibiotic resistance (Gaze et al., 2005;
Hegstad et al., 2010), and probably had a role in the origin of the
class 1 integrons responsible for the widespread dissemination of
antibiotic resistance amongst gram negative organisms (Gillings
et al., 2008b).
High rates of LGT occur between organisms in similar Phyla,
organisms with similar GC content, and organisms that occupy
the same environmental niches (Thomas and Nielsen, 2005; Popa
and Dagan, 2011). This activity creates lateral exchange commu-
nities, where DNA can be exchanged with relative ease (Beiko
et al., 2005; Kloesges et al., 2010; Skippington and Ragan, 2011).
Shared niches, and in particular, bioﬁlms, promote such exchanges
(Sorensen et al., 2005), and both conjugation and natural trans-
formation appear to be important in the process (Kloesges et al.,
2010; Domingues et al., 2012). While evolutionary distance and
difference in GC content can restrict LGT, there are mechanisms
for bypassing these barriers (Popa et al., 2011), and genes canmake
their way between distantly related organisms via a sequential
series of lateral transfers.
Human use of antibiotics is therefore having multiple effects
on the mobile components of the bacterial pangenome. One
would predict that the size of the mobilome as a proportion of
the pangenome is becoming larger, as more genes are recruited
onto mobile elements (Figure 2). The number of resistome ele-
ments now residing on mobile DNA is also increasing, given
that plasmids collected before the antibiotic era had no resis-
tance determinants (Datta and Hughes, 1983; Hughes and Datta,
1983), and modern plasmids of similar structure have acquired
a wide range of resistance genes dealing with various selective
agents in addition to antibiotics. Consequently, there is now a
greater overlap between the resistome and mobilome, particularly
with respect to genes of concern for human health and welfare
(Figure 2).
THE PANGENOME AND GLOBAL MICROBIOME
Human antibiotic use has pervasive effects on both the pangenome
and the local composition of the microbiome, largely because
antibiotics have non-target effects at gene, cell, and population
levels. Exposure of cells to antibiotics induces an SOS response
that has widespread effects on bacterial genomes, including rais-
ing the rates of mutation, recombination, and LGT (Tenaillon
et al., 2004; Aertsen and Michiels, 2006; Schlacher and Goodman,
2007). This increase in basal rates of evolution applies to all the
genes and cells in the exposed environment, not just the targets
of antibiotic therapy. Consequently, the release of antibiotics into
natural environments will affect the diversity of the pangenome
and the composition and ecology of the global microbiota (Couce
and Blázquez, 2009; Martinez, 2009a; Gillings and Stokes, 2012).
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Effects in particular environments have been demonstrated
experimentally. Short term antibiotic treatments lead to changes
in abundance, richness, and diversity of the human gut micro-
biota (Dethlefsen et al., 2008), which can remain perturbed for
years after treatment (Jakobsson et al., 2010; Sommer and Dan-
tas, 2011). The composition and functional diversity of soil
and sediment communities is affected by exposure to antibiotics
(Kong et al., 2006; Cordova-Kreylos and Scow, 2007), and persis-
tence of antibiotic residues in sediments or in the water column
leads to alteration of microbiota and in situ selection for antibi-
otic resistance (Cabello, 2006; Knapp et al., 2008). While pulses
of exposure to antibiotics may only produce transient selection
events, alterations to community composition, and the ﬁxation of
resistance genes and their mobile vectors may be permanent, with
unpredictable consequences for the whole microbiome (Martinez,
2009b; Gillings and Stokes, 2012).
ANTIBIOTICS AND RESISTANCE GENES AS POLLUTANTS
Antibiotics and their resistance genes originated from natural
environments, but human use of antibiotics has perturbed the
dynamics of this natural system. The high concentration of
antibiotics used prophylactically by humans has two main con-
sequences. Firstly, it leads to antibiotic contamination of human
waste streams, and secondly, the selection imposed by antibiotic
use has ﬁxed ever more complex genetic elements in commensals
andpathogens. These new“xenogenetic”elements are also released
via human waste streams. While antibiotics might be treated as
simple pollutants, xenogenetic mobile elements are capable of
replication, and are thus more akin to invasive species (Gillings
and Stokes, 2012).
Between 30 and 90% of the antibiotics given for human or
veterinary use are excreted essentially unchanged (Sarmah et al.,
2006). These compounds can be both persistent and mobile, and
are often not removed during sewage treatment (Watkinson et al.,
2007; Le-Minh et al., 2010; Zuccato et al., 2010). Antibiotics are
also released in high concentrations from facilities where antibi-
otics are produced (Li et al., 2009, 2010), and are disseminated
during application of manure to agricultural land (Chee-Sanford
et al., 2009; Heuer et al., 2011). The consequences of pollution
with antibiotics, particularly for aquatic systems, are being actively
examined (Taylor et al., 2011; Lupo et al., 2012), and there is a call
for development of policies to reduce the release of antibiotics and
bacteria via human waste streams (Baquero et al., 2008).
Waste streams that release antibiotics into the environment
also disseminate antibiotic resistance genes and mobile DNA ele-
ments, which should similarly be regarded as pollutants emanating
from human activity (Pruden et al., 2006; Martinez, 2009a; Stor-
teboom et al., 2010; Graham et al., 2011). The abundance of
resistance genes in soils has been increasing since the introduc-
tion of antibiotics in the 1940s (Knapp et al., 2009), in parallel
with the increasing concentrations of more conventional chemical
pollutants.
Resistance genes and complex mobile elements are commonly
reported from wastewater and sewage treatment plants (Tennstedt
et al., 2003; Zhang et al., 2009; Pellegrini et al., 2011). Wastewater
is regarded as a hotspot for interactions between mobile elements
and for their lateral transfer between pathogens, commensals, and
environmental bacteria (Schlüter et al., 2008; Moura et al., 2010).
Resistome and mobilome elements are not necessarily removed
by water treatment (Graham et al., 2011; Drudge et al., 2012),
allowing resistance genes to be used as markers of human inﬂu-
ence on aquatic ecosystems (Pei et al., 2006; Pruden et al., 2006;
Storteboom et al., 2010).
Domestic and agricultural animals are a source of signiﬁcant
quantities of antibiotics and resistance genes. Animal waste and
pig slurry are used to manure soils, with the consequent introduc-
tion of resistance genes and resistant bacteria (Binh et al., 2009;
Byrne-Bailey et al., 2009; Gaze et al., 2011). The long term fate of
antibiotics and resistance genes is difﬁcult to predictwithout quan-
titative measurements over appropriate timescales (Chee-Sanford
et al., 2009). However, it is clear that antibiotic resistant bacteria
will increase in abundance, lateral transfers to soil organisms will
occur, and resistance genes will be sequestered by diverse elements
of the mobilome (Heuer et al., 2011).
CONCLUSION
Human use of antibiotics for medicine and agriculture may have
consequences beyond their intended applications. Large quan-
tities of antibiotics now emanate from human waste streams,
as do the xenogenetic elements ﬁxed in human ecosystems by
antibiotic selection. Much more attention needs to be paid to the
origins and fates of such pollutants (Allen et al., 2010). The antibi-
otic revolution may be having effects across the entire microbial
biosphere (Martinez, 2009b), changing the basal rate of bac-
terial evolution, altering the composition of the resistome and
mobilome, and promoting lateral transfer of mobile genetic ele-
ments (Couce and Blázquez, 2009; Gillings and Stokes, 2012).
Antibiotic contamination promotes the ﬁxation and mobilization
of resistance genes between environmental and clinical microbiota
(Kristiansson et al., 2011), and resistance genes are now widely
spread through the biosphere (Martinez, 2009a; Stokes and
Gillings, 2011).
Above all, we need to address the antibiotic resistance problem
from a broader evolutionary and ecological perspective (Aminov
and Mackie, 2007; Baquero et al., 2009; Fajardo et al., 2009). The
ability of natural selection to shape species and communities is
the same for microorganisms as it is for larger species (Gillings
and Stokes, 2012), and the ecological theory of community assem-
bly developed for multicellular organisms can be applied to the
microbiome (Costello et al., 2012). The risk associated with the
environmental spread of resistance geneswith known adverse con-
sequences for human welfare has had little attention, nor has the
potential for pollution with antibiotics to widely affect the global
microbiome. In comparison, the potential escape of resistance
gene markers used in the generation of genetically modiﬁed plants
has been the subject of considerable research (Martinez, 2012). It is
time to pay more attention to the bioactive molecules that humans
release into the environment.
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